We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK’s MHRA to Cut 20 Percent of Drug Review Staff
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) plans to cut an estimated 20 percent of its workforce, around 300 employees — and aims to take a back-seat approach in approving generics and to rely on actions taken by EU and U.S. drug regulators.